These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37810555)

  • 41. Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9765049. PubMed ID: 37387973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retracted: CRNDE/ETS1/GPR17 Facilitates the Proliferation, Migration, and Invasion of Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9814841. PubMed ID: 37811263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Retracted] miR‑218 inhibits the migration and invasion of glioma U87 cells through the Slit2‑Robo1 pathway.
    Gu JJ; Gao GZ; Zhang SM
    Oncol Lett; 2023 Nov; 26(5):481. PubMed ID: 37818138
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Jiang W; Zheng F; Yao T; Gong F; Zheng W; Yao N
    Ann Transl Med; 2021 Nov; 9(22):1686. PubMed ID: 34988195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retracted: Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9790735. PubMed ID: 37810565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retracted: miR-190a-3p Promotes Proliferation and Migration in Glioma Cells via YOD1.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9892428. PubMed ID: 37811225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retracted: TMEM60 Promotes the Proliferation and Migration and Inhibits the Apoptosis of Glioma through Modulating AKT Signaling.
    Oncology JO
    J Oncol; 2023; 2023():9767535. PubMed ID: 36727156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
    Markers D
    Dis Markers; 2023; 2023():9849123. PubMed ID: 37593569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retracted: miR-381-3p Involves in Glioma Progression by Suppressing Tumor-Promoter Factor ANTXR1.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9850987. PubMed ID: 37811310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retracted: Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9819050. PubMed ID: 37388514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retracted: SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma.
    Journal Of Oncology
    J Oncol; 2023; 2023():9813986. PubMed ID: 37476559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retracted: FAM87A as a Competing Endogenous RNA of miR-424-5p Suppresses Glioma Progression by Regulating PPM1H.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9769738. PubMed ID: 37811266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Retracted] Long non‑coding RNA RNCR3 promotes glioma progression involving the Akt/GSK‑3β pathway.
    Zhu B; Zhang S; Meng N; Zhang H; Yuan S; Zhang J
    Oncol Lett; 2023 Nov; 26(5):468. PubMed ID: 37780546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retracted: Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer.
    Markers D
    Dis Markers; 2023; 2023():9810178. PubMed ID: 37387742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retracted: Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9792854. PubMed ID: 37829426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retracted: Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma.
    Oncology JO
    J Oncol; 2023; 2023():9832716. PubMed ID: 37476550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retracted: Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
    International BR
    Biomed Res Int; 2023; 2023():9803081. PubMed ID: 37475820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retracted: Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9806931. PubMed ID: 37564810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
    Ye L; Tong S; Wang Y; Wang Y; Ma W
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.